Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation-Reference-Cited by-同舟云学术

Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation

Published:2023-05-11 Issue:9 Volume:15 Page:3839-3856
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Li Xia¹,Du Yuhua¹,Huang Shicong¹,Yang Yi²,Lu Doudou³,Zhang Junfei³,Chen Yan⁴,Zhang Lei⁵,Nan Yi⁴⁵,Yuan Ling¹

Affiliation:

1. College of Pharmacy, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China

2. College of Basic Medicine, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China

3. College of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China

4. Traditional Chinese Medicine College, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China

5. Key Laboratory of Hui Ethnic Medicine Modernization of Ministry of Education, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference39 articles.

1. Gastric cancer.;Lordick;Lancet,2020

2. The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer.;Rezaei;Int Rev Immunol,2022

3. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.;Dingding;Biomed Pharmacother,2017

4. Cancer treatment and survivorship statistics, 2019.;Siegel;CA Cancer J Clin,2019

5. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.;Lin;Med Sci Monit,2020